Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

193.49
Delayed Data
As of Jul 22
 +0.03 / +0.02%
Today’s Change
147.60
Today|||52-Week Range
270.63
-5.61%
Year-to-Date
3 Stocks Pushing The Drugs Industry Downward
Jul 21 / TheStreet.com - Paid Partner Content
Shire's (SHPG) Dry Eye Disease Drug Xiidra Gets FDA Nod
Jul 12 / Zacks.com - Paid Partner Content
Company News for July 13, 2016
Jul 13 / Zacks.com - Paid Partner Content
Stocks: 5 things to know before the open
Jul 12 / CNNMoney.com

Today’s Trading

Previous close193.46
Today’s open192.29
Day’s range191.62 - 193.87
Volume836,203
Average volume (3 months)2,835,423
Market cap$58.0B
Dividend yield0.70%
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-61.89%
Earnings growth (this year)+9.16%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+6.79%
P/E ratio28.6
Price/Sales6.33
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.13+0.30%
AZNAstraZeneca+0.60+1.97%
CELGCelgene+0.07+0.07%
ALXNAlexion Pharmaceutic...-1.50-1.18%
Data as of 4:03pm ET, 07/22/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$3.08
Annual revenue (last year)$6.4B
Annual profit (last year)$1.3B
Net profit margin20.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs